MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 109 filers reported holding MIRUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,343,535 | +38.6% | 1,434,922 | +13.4% | 1.82% | +18.0% |
| Q2 2023 | $32,723,532 | +85.4% | 1,264,922 | +72.1% | 1.55% | +40.8% |
| Q1 2023 | $17,652,826 | +139.9% | 734,922 | +94.7% | 1.10% | +105.8% |
| Q4 2022 | $7,358,793 | -74.3% | 377,374 | -72.3% | 0.53% | -68.1% |
| Q3 2022 | $28,674,000 | +6.3% | 1,364,786 | -1.5% | 1.68% | -8.0% |
| Q2 2022 | $26,972,000 | +64.4% | 1,385,997 | +86.0% | 1.82% | +122.5% |
| Q1 2022 | $16,405,000 | – | 745,000 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |